Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
| Report ID | 235624 |
| Drug Identification Number | 02402076 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
| Strength(s) | 0.375G 3G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | Vial |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-08-21 |
| Estimated end date | Unknown |
| Actual end date | 2025-02-18 |
| Shortage status | Resolved |
| Updated date | 2025-02-19 |
| Company comments | Please be informed PIPERACILLIN AND TAZOBACTAM FOR INJECTION is now available under Eugia label DIN: 02528703 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v14 | 2025-02-19 | French | Compare |
| v13 | 2025-02-19 | English | Compare |
| v12 | 2024-10-28 | French | Compare |
| v11 | 2024-10-28 | English | Compare |
| v10 | 2024-10-28 | English | Compare |
| v9 | 2024-09-19 | French | Compare |
| v8 | 2024-09-19 | English | Compare |
| v7 | 2024-08-29 | French | Compare |
| v6 | 2024-08-29 | English | Compare |
| v5 | 2024-08-23 | French | Compare |
| v4 | 2024-08-23 | English | Compare |
| v3 | 2024-08-22 | English | Compare |
| v2 | 2024-08-21 | French | Compare |
| v1 | 2024-08-21 | English | Compare |
Showing 1 to 14 of 14